FDA NEWS RELEASE
For Immediate Release: Aug. 2, 2011
Media Inquiries: Siobhan DeLancey, 202-510-4177, siobhan.delancey@fda.hhs.gov
Trade Inquiries: Stephen King, 240-402-1407, stephen.king@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA
FDA reopens comment period on proposed ‘gluten-free’ food labeling rule
Rule would help by creating a uniform and enforceable definition
The U.S. Food and Drug Administration today
reopened the comment period for its 2007 proposal on labeling foods as
“gluten-free.” The agency is also making available a safety assessment
of exposure to gluten for people with celiac disease (CD) and invites
comment on these additional data.
One
of the criteria proposed is that foods bearing the claim cannot contain
20 parts per million (ppm) or more gluten. The agency based the
proposal, in part, on the available methods for gluten detection. The
validated methods could not reliably detect the amount of gluten in a
food when the level was less than 20 ppm. The threshold of less than 20
ppm also is similar to “gluten-free” labeling standards used by many
other countries.
People
who have celiac disease cannot tolerate gluten, a protein in wheat,
rye, and barley. Celiac disease damages the small intestine and
interferes with absorption of nutrients from food. About 1 percent of
the United States population is estimated to have the disease.
“Before
finalizing our gluten-free definition, we want up-to-date input from
affected consumers, the food industry, and others to help assure that
the label strikes the right balance,” said Michael Taylor, deputy
commissioner for foods. “We must take into account the need to protect
individuals with celiac disease from adverse health consequences while
ensuring that food manufacturers can meet the needs of consumers by
producing a wide variety of gluten-free foods.”
The
proposed rule conforms to the standard set by the Codex Alimentarius
Commission in 2008, which requires that foods labeled as “gluten-free”
not contain more than 20 ppm gluten. This standard has been adopted in
regulations by the 27 countries composing the Commission of European
Communities.
The
FDA encourages members of the food industry, state and local
governments, consumers, and other interested parties to offer comments
and suggestions about gluten-free labeling in docket number
FDA-2005-N-0404 at www.regulations.gov. The docket will officially open for comments after noon on Aug 3, 2011 and will remain open for 60 days.
To submit your comments electronically to the docket go to www.regulations.gov
1. Choose “Submit a Comment” from the top task bar
2. Enter the docket number FDA-2005-N-0404 in the “Keyword” space
3. Select “Search”
2. Enter the docket number FDA-2005-N-0404 in the “Keyword” space
3. Select “Search”
To submit your comments to the docket by mail, use the following address:
The Division of Dockets Management
HFA-305
Food and Drug Administration
5630 Fishers Lane, Room 1061
Rockville, MD 20852
Include docket number FDA-2005-N-0404 on each page of your written comments.
HFA-305
Food and Drug Administration
5630 Fishers Lane, Room 1061
Rockville, MD 20852
Include docket number FDA-2005-N-0404 on each page of your written comments.
For more information:
Federal Register Notice (scroll to FDA--temporary link will update when document publishes on Aug. 3):
Gluten-Free Portal (scroll to Gluten-Free):
FDA’s Proposed Rule on the Gluten-Free Labeling of Foods: http://www.fda.gov/Food/LabelingNutrition/FoodAllergensLabeling/GuidanceComplianceRegulatoryInformation/ucm077926.htm
Questions and Answers on the Gluten-Free Labeling Proposed Rule:
Consumer Update on the Gluten-Free Labeling Proposed Rule:
1 comments:
You don't suppose the letter from 2 senators had anything to do with this, do you?
Post a Comment